SGLT2 Inhibitors and the Risk of Arrhythmias in Heart Failure: A Network Meta-Analysis

By afschroeder • August 14, 2025

Suresh SB, Prasad A, Ubaid MF, Farooq S, Hajra A, Jaiswal V, Malik A, Fonarow GC, Bandyopadhyay D. SGLT2 Inhibitors and the Risk of Arrhythmias in Heart Failure: A Network Meta-Analysis. J Clin Med. 2025 Jul 27;14(15):5306. doi: 10.3390/jcm14155306. PMID: 40806928.

Tags: arrhythmia, atrial fibrillation, Cardiology/Epi, Publications, sodium-glucose cotransporter-2 inhibitor, Sudden cardiac death

Ventricular Tachycardia Predicts All-Cause Mortality and Nonsudden Cardiac Death in Nonischemic Cardiomyopathy

Omara S, Jensen TN, Koeber L, Thune JJ, Pehrson S, Mertens B, Tedrow UB, Hindricks G, Ebert M, Carbucicchio C, Berruezo A, Vaseghi M, Shivkumar[...]

A novel application of LC-MS/MS accurately quantifies the labile redox pools of cellular coenzymes Q9 and Q10

Jain A, Li VW, Salem J, Reddy ST, Palaskas NJ, Meriwether D. A novel application of LC-MS/MS accurately quantifies the labile redox pools of cellular[...]

Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate

Behrenbruch C, Herrmann K, Czernin J. Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on[...]